Previous studies have shown the therapeutic effects of clonazepam for rapid eye movement sleep behavior disorder (RBD), but they had several limitations such as the lack of clear definition of treatment outcomes and little information about adjuvant therapy. The aims of this study were to evaluate the treatment outcomes with clonazepam and to explore possible determinants of treatment response. We performed a retrospective medical chart review of 171 patients with RBD. All the participants underwent overnight polysomnography and completed questionnaires. The positive treatment response was defined as the absence of disruptive behaviors causing sleep-related injuries during the last year of follow-up. Among the 171 patients presented with disruptive behaviors, 155 (90.6%) experienced positive treatment responses. Of the responders, 18 (11.6%) received adjunctive medication due to insufficient therapeutic effect of clonazepam monotherapy. After adjusted analysis, an earlier age of diagnosis (odds ratio [OR] = 0.74, 95% confidence interval [CI] = 0.64–0.86, P < .001) and comorbid periodic limb movement during sleep (OR = 4.96, 95% CI = 1.05–23.33, P = .043) were related to poor treatment response. Clinicians should recognize the predictors of poor treatment response and consider combination therapy for better prevention of sleep-related injuries in those who show unsatisfactory responses to clonazepam monotherapy.
SchenckCHBundlieSREttingerMGMahowaldMW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293–308.
2.
SchenckCHBundlieSRPattersonALMahowaldMW. Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA. 1987;257(13):1786–1789.
3.
BoeveBFOlsonEJSilberMH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123(2):331–339.
4.
SchenckCHHurwitzTDMahowaldMW. Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res. 1993;2(4):224–231.
5.
ComellaCLNardineTMDiederichNJStebbinsGT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology. 1998;51(2):526–529.
6.
LamSPWongCCLiSX, et al.Caring burden of REM sleep behavior disorder—spouses’ health and marital relationship. Sleep Med. 2016;24:40–43.
7.
McCarterSJLouisEKSBoswellCL, et al.Factors associated with injury in REM sleep behavior disorder. Sleep Medi. 2014;15(11):1332–1338.
8.
AuroraRNZakRSMagantiRK, et al.Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6(1):85–95.
9.
IranzoAMolinuevoJLSantamariaJ, et al.Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572–577.
10.
SchenckCHMahowaldMW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100(3):333–337.
11.
WingYKLamSPLiSX, et al.REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry. 2008;79(12):1415–1416.
12.
ShinCParkHLeeW-WKimH-JKimH-JJeonB. Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: a randomized placebo-controlled trial. J Neurol Sci. 2019;401:81–86.
13.
LiSXLamSPZhangJ, et al.A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med. 2016;21:114–120.
14.
IberCAncoli-IsraelSChessonALQuanSF. The AASM Manual for the Scoring of Sleep and Associated Events. Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine, 2007.
15.
BuysseDJReynoldsCF3rdMonkTHBermanSRKupferDJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
16.
JohnsMW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540–545.
17.
BeckATSteerRABrownGK. Beck Depression Inventory (2nd manual). San Antonio, TX: The Psychological Corporation; 1996.
18.
YounSKimTYoonI-Y, et al.Progression of cognitive impairments in idiopathic REM sleep behaviour disorder. J Neurol Neurosurg Psychiatry. 2016;87(8):890–896.
19.
PostumaRB. Predicting neurodegenerative disease in idiopathic rapid eye movement (REM) sleep behavior disorder: Conference proceedings, REM Sleep Behavior Symposium 2011. Sleep Biol Rhythms. 2013;11(1):75–81.
20.
InoueY. Asian specific feature of sleep habits and sleep disorders. Sleep Biol Rhythms. 2016;14(2):123–124.
21.
BamfordCR. Carbamazepine in REM sleep behavior disorder. Sleep. 1993;16(1):33–34.
22.
SchenckCHBoydJLMahowaldMW. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep. 1997;20(11):972–981.
23.
AndersonKNShneersonJM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med. 152009;5(3):235–239.
24.
BonakisAHowardRSWilliamsA. Narcolepsy presenting as REM sleep behaviour disorder. Clin Neurol Neurosurg. 2008;110(5):518–520.
25.
ZakRSMagantiRKAuerbachSH, et al.Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6(01):85–95.
26.
SchenckCHHowellMJ. Clonazepam and other therapies of RBD. In: SchenckCHöglBVidenovicA, eds. Rapid-Eye-Movement Sleep Behavior Disorder. Berlin, Germany: Springer, 2019:333–345.
27.
McGraneIRLeungJGLouisEKSBoeveBF. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Med. 2015;16(1):19–26.
28.
MoghadamKKPizzaFPrimaveraAFerriRPlazziG. Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients. Sleep Med.2017;32:16–21.
29.
BonakisAHowardRSEbrahimIOMerrittSWilliamsA. REM sleep behaviour disorder (RBD) and its associations in young patients. Sleep Med. 2009;10(6):641–645.
30.
TemanPTTippmann-PeikertMSilberMHSlocumbNLAugerRR. Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med. 2009;10(1):60–65.
31.
ZhouJZhangJDuL, et al.Characteristics of early- and late-onset rapid eye movement sleep behavior disorder in China: a case-control study. Sleep Med. 2014;15(6):654–660.
32.
SumiYMatsuoMNakabayashiT, et al.Changes in the symptom frequency of rapid eye movement sleep behavior disorder according to disease duration. Sleep Sci Pract. 2017;1(1):16.
33.
FantiniMMichaudMGosselinNLavigneGMontplaisirJ. Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation. Neurology. 2002;59(12):1889–1894.
34.
ManconiMFerriRZucconiMFantiniMLPlazziGFerini-StrambiL. Time structure analysis of leg movements during sleep in REM sleep behavior disorder. Sleep. 2007;30(12):1779–1785.
35.
SasaiTMatsuuraMInoueY. Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord. 2013;19(2):153–157.
